Multimodality Cardiovascular Imaging in the Midst of the COVID-19 Pandemic

[1]  Randall C. Thompson,et al.  Guidance and Best Practices for Reestablishment of Non-Emergent Care in Nuclear Cardiology Laboratories During the Coronavirus Disease 2019 (COVID-19) Pandemic: An Information Statement from ASNC, IAEA, and SNMMI , 2021, Journal of nuclear medicine technology.

[2]  E. Romano.  Association of Cardiac Injury with Mortality in Hospitalized Patients with COVID-19. , 2021, Arquivos brasileiros de cardiologia.

[3]  Randall C. Thompson,et al.  Guidance and best practices for reestablishment of non-emergent care in nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: An information statement from ASNC, IAEA, and SNMMI , 2020, Journal of Nuclear Cardiology.

[4]  C. Kramer,et al.  Cardiovascular Imaging Techniques to Assess Microvascular Dysfunction. , 2020, JACC. Cardiovascular imaging.

[5]  M. Swaminathan,et al.  ASE Statement on the Reintroduction of Echocardiographic Services during the COVID-19 Pandemic , 2020, Journal of the American Society of Echocardiography.

[6]  L. Kucirka,et al.  Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction–Based SARS-CoV-2 Tests by Time Since Exposure , 2020, Annals of Internal Medicine.

[7]  Allen E. Packard,et al.  Safe Reintroduction of Cardiovascular Services During the COVID-19 Pandemic , 2020, Journal of the American College of Cardiology.

[8]  Yu-Xuan Cai,et al.  Prognostic Value of Right Ventricular Longitudinal Strain in Patients With COVID-19 , 2020, JACC: Cardiovascular Imaging.

[9]  W. Manning,et al.  Society for Cardiovascular Magnetic Resonance (SCMR) guidance for the practice of cardiovascular magnetic resonance during the COVID-19 pandemic , 2020, Journal of Cardiovascular Magnetic Resonance.

[10]  G. Pontone,et al.  “Quadruple Rule-Out” With Computed Tomography in a COVID-19 Patient With Equivocal Acute Coronary Syndrome Presentation , 2020, JACC: Cardiovascular Imaging.

[11]  J. Kirkpatrick,et al.  ASE Statement on Point-of-Care Ultrasound during the 2019 Novel Coronavirus Pandemic , 2020, Journal of the American Society of Echocardiography.

[12]  S. Plein,et al.  Rapid Cardiovascular Magnetic Resonance for Ischemic Heart Disease Investigation (RAPID-IHD). , 2020, JACC. Cardiovascular imaging.

[13]  G. Pontone,et al.  COVID-19 pandemic and cardiac imaging: EACVI recommendations on precautions, indications, prioritization, and protection for patients and healthcare personnel , 2020, European heart journal cardiovascular Imaging.

[14]  W. Gong,et al.  Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. , 2020, JAMA cardiology.

[15]  R. Lu,et al.  Detection of SARS-CoV-2 in Different Types of Clinical Specimens. , 2020, JAMA.

[16]  A. Ferguson.  Coronavirus - COVID-19 , 2020 .

[17]  G. Feuchtner,et al.  Society of Cardiovascular Computed Tomography guidance for use of cardiac computed tomography amidst the COVID-19 pandemic Endorsed by the American College of Cardiology , 2020, Journal of Cardiovascular Computed Tomography.

[18]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[19]  L. Chebrolu,et al.  LEFT VENTRICULAR NONCOMPACTION WITH EBSTEIN ANOMALY SECONDARY TO MYH7 MUTATION , 2020 .

[20]  H. Elming,et al.  Coronary CT Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome. , 2020, Journal of the American College of Cardiology.

[21]  M. Swaminathan,et al.  ASE Statement on Protection of Patients and Echocardiography Service Providers During the 2019 Novel Coronavirus Outbreak , 2020, Journal of the American College of Cardiology.

[22]  P. Dagnelie,et al.  Initial Imaging-Guided Strategy Versus Routine Care in Patients With Non-ST-Segment Elevation Myocardial Infarction. , 2019, Journal of the American College of Cardiology.

[23]  Y. Wang,et al.  Cardiac MRI for detecting left atrial/left atrial appendage thrombus in patients with atrial fibrillation , 2019, Herz.

[24]  V. Dilsizian,et al.  FDG PET/CT for Early Detection and Localization of Left Ventricular Assist Device Infection: Impact on Patient Management and Outcome. , 2019, JACC. Cardiovascular imaging.

[25]  Michael E. Hall,et al.  ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2019 appropriate use criteria for multimodality imaging in the assessment of cardiac structure and function in nonvalvular heart disease: A report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic , 2019, The Journal of thoracic and cardiovascular surgery.

[26]  Y. Kim,et al.  Comparison of Cardiac Computed Tomography With Transesophageal Echocardiography for Identifying Vegetation and Intracardiac Complications in Patients With Infective Endocarditis in the Era of 3-Dimensional Images , 2018, Circulation. Cardiovascular imaging.

[27]  Harald Becher,et al.  Clinical Applications of Ultrasonic Enhancing Agents in Echocardiography: 2018 American Society of Echocardiography Guidelines Update. , 2018, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[28]  E. Nagel,et al.  High-throughput gadobutrol-enhanced CMR: a time and dose optimization study , 2017, Journal of Cardiovascular Magnetic Resonance.

[29]  P. Schoenhagen,et al.  ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2017 Appropriate Use Criteria for Multimodality Imaging in Valvular Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society , 2017, Journal of the American College of Cardiology.

[30]  L. Cooper,et al.  Joint SNMMI–ASNC Expert Consensus Document on the Role of 18F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring , 2017, The Journal of Nuclear Medicine.

[31]  V. Dilsizian,et al.  Myocardial Viability: Survival Mechanisms and Molecular Imaging Targets in Acute and Chronic Ischemia , 2017, Circulation research.

[32]  D. Berman,et al.  CMR First-Pass Perfusion for Suspected Inducible Myocardial Ischemia. , 2016, JACC. Cardiovascular imaging.

[33]  V. Dilsizian,et al.  ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures , 2016, Journal of Nuclear Cardiology.

[34]  M. Quiñones,et al.  Detection of LA and LAA Thrombus by CMR in Patients Referred for Pulmonary Vein Isolation. , 2016, JACC. Cardiovascular imaging.

[35]  James C Moon,et al.  Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis , 2016, Circulation.

[36]  J. Zamorano,et al.  [2015 ESC Guidelines for the management of infective endocarditis]. , 2015, Kardiologia polska.

[37]  Alan S. Brown,et al.  ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Societ , 2014, Journal of cardiac failure.

[38]  G. Ronan,et al.  ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 Multimodality Appropriate Use Criteria for the Detection and Risk Assessment of Stable Ischemic Heart Disease , 2013, Journal of Nuclear Cardiology.

[39]  Richard D. White,et al.  2013 ACCF/ACR/ASE/ASNC/SCCT/SCMR appropriate utilization of cardiovascular imaging in heart failure: a joint report of the American College of Radiology Appropriateness Criteria Committee and the American College of Cardiology Foundation Appropriate Use Criteria Task Force. , 2013, Journal of the American College of Cardiology.

[40]  Manesh R. Patel,et al.  Appropriate use of cardiovascular technology: 2013 ACCF appropriate use criteria methodology update: a report of the American College of Cardiology Foundation appropriate use criteria task force. , 2013, Journal of the American College of Cardiology.

[41]  Warren J Manning,et al.  ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 Appropriate Use Criteria for Echocardiography. A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Society of Echocardiography, American Heart Association, American Society of Nuclear Cardiology, , 2011, Journal of the American College of Cardiology.

[42]  M. Swaminathan,et al.  ASE Statement on Protection of Patients and Echocardiography Service Providers During the 2019 Novel Coronavirus Outbreak KHUYẾN CÁO CỦA HỘI SIÊU ÂM TIM HOA KỲ VỀ , 2020 .

[43]  Alan S. Brown,et al.  ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2017 Appropriate Use Criteria for Multimodality Imaging in Valvular Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society , 2018, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[44]  G. Feuchtner,et al.  Cardiac CTA for Evaluation of Prosthetic Valve Dysfunction. , 2017, JACC. Cardiovascular imaging.

[45]  S. Abbara.  ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 Appropriate Use Criteria for Cardiac Computed Tomography , 2011 .

[46]  Alan S. Brown,et al.  ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 appropriate use criteria for cardiac computed tomography. A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American , 2010, Journal of the American College of Cardiology.

[47]  K. Jenpanich,et al.  [Drug administration]. , 1976, Thai journal of nursing.